Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.

Journal of virology - 1 Apr 1991

Wang F, Marchini A, Kieff E

Abstract excerpt

The objective of these experiments was to develop strategies for creation and identification of recombinant mutant Epstein-Barr viruses (EBV). EBV recombinant molecular genetics has been limited to mutations within a short DNA segment deleted from a nontransforming EBV and an underlying strategy which relies on growth transformation of primary B lymphocytes for identification of recombinants. Thus, mutations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Viral
Share to Cell Nucleus
Share to Drug Resistance, Microbial

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Expression

Share to Genes, Viral

Share to Genetic Markers

Share to Mutation

Share to Tumor Cells, Cultured

Source

Open in PubMed Open full text

Identifiers

PMID: 1848303
DOI: 10.1128/JVI.65.4.1701-1709.1991
PMCID: PMC239974

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.PMID 1848303Read ↗

A selectable marker allows investigation of a nontransforming Epstein-Barr virus mutant.Semantic proximity Read ↗

The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy.Semantic proximity Read ↗

Virally targeted therapies for EBV-associated malignancies.Semantic proximity Read ↗

Immortalization of human primary B lymphocytes in vitro with DNA.Semantic proximity Read ↗

Eradication of Epstein-Barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1.Semantic proximity Read ↗

Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis.Semantic proximity Read ↗

A comprehensive library of mutations of Epstein Barr virus.Semantic proximity Read ↗

Systematic analysis of Epstein-Barr virus genes and their individual contribution to virus production and compositionSemantic proximity Read ↗

Development of a Novel Helper-Dependent Adenovirus-Epstein-Barr Virus Hybrid System for the Stable Transformation of Mammalian CellsSemantic proximity Read ↗

The latent membrane protein 2 gene of Epstein-Barr virus is important for efficient B cell immortalization.Semantic proximity Read ↗

High-frequency transformation of human repair-deficient cell lines by an Epstein-Barr virus-based cDNA expression vector.Semantic proximity Read ↗

Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.